Tirzepatide is a once-weekly injectable medication used to treat type 2 diabetes and assist with weight management. It works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. By mimicking these hormones, Tirzepatide helps regulate blood sugar levels, slow digestion, reduce appetite, and promote fat loss. Its dual action makes it highly effective for improving insulin sensitivity and supporting weight reduction in patients with obesity or metabolic disorders.

Tirzepatide not only lowers blood glucose but also enhances satiety, leading to reduced calorie intake and significant weight loss. Common side effects include nausea, vomiting, diarrhea, and constipation, which typically decrease over time. Serious but rare side effects may include pancreatitis, gallbladder issues, and low blood sugar when combined with other diabetes medications. It is often prescribed alongside diet and exercise, with regular monitoring to ensure safety and effectiveness.